Wilms Tumor: Clinical Trials

203 trials for Wilms Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

122 completed, 24 recruiting, 16 active not recruiting, 16 unknown. 72 Phase 1, 67 Phase 2, 19 Phase 3, 18 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 172Completed 42, Recruiting 12, Terminated 7, Active not recruiting 6, Unknown 3, Withdrawn 2
Phase 267Completed 35, Active not recruiting 10, Recruiting 10, Terminated 5, Unknown 5, Withdrawn 2
Phase 319Completed 14, Unknown 3, Terminated 2
Not applicable18Completed 11, Unknown 3, Withdrawn 3, Recruiting 1
Phase 42Completed 1, Not yet recruiting 1
Early Phase 11Recruiting 1

Follow Wilms Tumor: new trials by email Literature Review of Wilms Tumor trials Research Report on Wilms Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Denys-Drash Syndrome and Risk of Post-transplant Lymphoproliferative Disorder
Collection of data from the patient's medical file - Denys-Drash Syndrome
Not yet recruitingAssistance Publique - Hôpitaux de Paris1082026-06-012026-05-26
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
Becotatug Vedotin - Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Nasopharyngeal Carcinoma
Phase 1RecruitingSun Yat-sen University512026-05-302026-05-13
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Miltenyi CliniMACS Prodigy ® system, Zoledronic acid - Neuroblastoma, Rhabdomyosarcoma
Phase 1 / Phase 2RecruitingUniversity of Florida272026-02-112026-06-30
Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Selective Antigen Specific dTβRII-expressing T cells combined with B7-H3 CAR T cells - Rhabdomyosarcoma, Ewing Sarcoma
Phase 1RecruitingChildren's National Research Institute182026-01-272026-08-13
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Liver Cell Carcinoma
Phase 1RecruitingSeattle Children's Hospital212025-12-222026-02-17
INVESTIGATION OF THE GENETIC ETIOLOGY OF HERNIA SAC DEVELOPMENT IN MALE CHILDREN WITH UNDESCENDED TESTIS AND INGUINAL HERNIA
Indirect Inguinal Hernia, Undescended Testis
Active not recruitingTrakya University32025-09-092026-05-14
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
21.15.GPC3-CAR T cells - Hepatoblastoma, Hepatocellular Carcinoma
Phase 1RecruitingBaylor College of Medicine212025-06-102025-11-03
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Quality of Life (QOL), Patient-Reported Outcome Measures (PROMs)
Not yet recruitingRenJi Hospital3602025-04-012025-03-13
Accurate Diagnosis and Grading of Pediatric Solid Tumors Based on Pathological Large Models
Neuroblastoma, Medulloblastoma
CompletedXinhua Hospital, Shanghai Jiao Tong University School of Medicine12292025-01-222026-08-04
Biomarkers of Resiliency In Childhood Cancer Surgery
Wearing Smartwatch, Patient Report Outcomes, Blood Draw - Pediatric Cancer, Neuroblastoma
RecruitingMayo Clinic402025-01-152026-09-14
Physical Activity and Community EmPOWERment Project
PACE Program - Intellectual Disability, Neurodevelopmental Disorders
Not applicableRecruitingUniversity of North Carolina, Chapel Hill3762025-01-102026-02-23
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
CARE T cells - Liver Cancer, Rhabdomyosarcoma
Phase 1RecruitingBaylor College of Medicine242024-05-242026-08-06
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Selinexor - Wilms Tumor, Rhabdoid Tumor
Phase 2RecruitingMemorial Sloan Kettering Cancer Center452023-08-012026-10-23
Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma
Dendritic cell vaccination, Atezolizumab, Platinum/pemetrexed based chemotherapy - Malignant Pleural Mesothelioma
Phase 1 / Phase 2RecruitingUniversity Hospital, Antwerp152023-02-242026-06-05
Nephrogreen. Appearances of Exvivo Renal Tumours Under Near-infrared
Indocyanine Green (ICG) - Wilms Tumor, Renal Cancer
Not applicableCompletedBirmingham Women's and Children's NHS Foundation Trust122023-02-012025-03-04
Vascular Thrombus Involvement in Nephroblastoma
Nephroblastoma With Vena Cava Thrombosis
CompletedAssistance Publique - Hôpitaux de Paris722022-12-122025-09-12
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Magnetic Resonance-Guided High Intensity Focused Ultrasound, Lyso-thermosensitive Liposomal Doxorubicin - Solid Tumors, Soft Tissue Sarcoma
Phase 2WithdrawnChildren's National Research Institute2022-11-102025-01-01
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
Vincristine, Irinotecan, Temozolomide - Wilms Tumor
Phase 1 / Phase 2RecruitingCentre Oscar Lambret282022-09-142026-03-18
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
Cabozantinib - Neuroblastoma, Sarcoma
Phase 2RecruitingNationwide Children's Hospital862022-07-202025-08-12
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Fludarabine, Cyclophosphamide, MESNA - Pediatric Solid Tumor, Osteosarcoma
Phase 1RecruitingSt. Jude Children's Research Hospital482022-07-062026-05-19

Showing 20 of 203. Sign in to see all of them.

Narrower conditions

Neuroblastoma (112)  ·  Sarcoma (80)  ·  Osteosarcoma (59)  ·  Rhabdomyosarcoma (59)  ·  Sarcoma, Ewing (50)  ·  Kidney Neoplasms (43)  ·  Neoplasms (43)  ·  Lymphoma, Non-Hodgkin (42)  ·  Medulloblastoma (42)  ·  Burkitt Lymphoma (40)  ·  Neuroectodermal Tumors, Primitive, Peripheral (39)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (39)  ·  Recurrence (39)  ·  Testicular Neoplasms (39)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (203)  ·  Female Urogenital Diseases (203)  ·  Female Urogenital Diseases and Pregnancy Complications (203)  ·  Kidney Diseases (203)  ·  Male Urogenital Diseases (203)  ·  Neoplasms by Histologic Type (203)  ·  Neoplasms by Site (203)  ·  Neoplasms, Complex and Mixed (203)  ·  Neoplastic Syndromes, Hereditary (203)  ·  Urogenital Diseases (203)  ·  Urogenital Neoplasms (203)  ·  Urologic Diseases (203)  ·  Genetic Diseases, Inborn (202)  ·  Urologic Neoplasms (202)  ·  Kidney Neoplasms (160)

Interventions

Cyclophosphamide (16)  ·  Vincristine (16)  ·  Filgrastim (13)  ·  Doxorubicin (12)  ·  Etoposide (12)  ·  Radiotherapy (11)  ·  Carboplatin (10)  ·  Dactinomycin (9)  ·  Magnetic Resonance Spectroscopy (9)  ·  Specimen Handling (9)  ·  X-Rays (9)  ·  Granulocyte Colony-Stimulating Factor (8)  ·  Phantoms, Imaging (8)  ·  Ifosfamide (6)  ·  Melphalan (6)

Sponsors

National Cancer Institute (NCI) (31)  ·  Children's Oncology Group (28)  ·  Fred Hutchinson Cancer Center (10)  ·  Memorial Sloan Kettering Cancer Center (8)  ·  St. Jude Children's Research Hospital (6)  ·  M.D. Anderson Cancer Center (5)  ·  Baylor College of Medicine (4)  ·  Emory University (4)  ·  National Institutes of Health Clinical Center (CC) (4)  ·  Sumitomo Pharma America, Inc. (4)  ·  Children's National Research Institute (3)  ·  City of Hope Medical Center (3)  ·  Masonic Cancer Center, University of Minnesota (3)  ·  Seattle Children's Hospital (3)  ·  AeRang Kim (2)

Countries

United States (158)  ·  Canada (22)  ·  Puerto Rico (22)  ·  Australia (21)  ·  France (10)  ·  New Zealand (9)  ·  China (8)  ·  United Kingdom (8)  ·  Switzerland (7)  ·  Germany (6)  ·  Israel (6)  ·  Netherlands (6)  ·  Italy (5)  ·  Belgium (4)  ·  Spain (4)

Top investigators

AeRang Kim, MD, PhD (4)  ·  Brian H. Kushner, MD (3)  ·  David Steffin, MD (3)  ·  Elizabeth A Mullen (3)  ·  AeRang Kim, MD (2)  ·  Andrea Hayes-Jordan, MD (2)  ·  Daniel M. Green, MD (2)  ·  Elizabeth Fox, MD (2)  ·  Elizabeth J. Perlman, MD (2)  ·  Elizabeth Perlman, MD (2)  ·  Holly Meany, MD (2)  ·  James I Geller (2)  ·  Jan DeKraker, MD (2)  ·  Kenneth G. Lucas, MD (2)  ·  Thomas J. Walsh, MD (2)

Results publications

PMID 31401903, PMID 37933882, PMID 19556464, PMID 25209242, PMID 29343557, PMID 31449468, PMID 38396300, PMID 10463285, PMID 15175957, PMID 15459300, PMID 15542800, PMID 15654272, PMID 15814645, PMID 15868587, PMID 16129848, PMID 16172460, PMID 16234526, PMID 16410127, PMID 16547940, PMID 16710034, PMID 16914576, PMID 17084075, PMID 17539021, PMID 18281544, PMID 18391430, PMID 18811224, PMID 18989885, PMID 19075272, PMID 19208794, PMID 19231157, PMID 19300220, PMID 19430790, PMID 20044751, PMID 20332316, PMID 20460632, PMID 20582946, PMID 21189373, PMID 21319349, PMID 21703848, PMID 22504933, PMID 22952427, PMID 23015404, PMID 23382471, PMID 23441092, PMID 23897077, PMID 24481001, PMID 24761742, PMID 24821309, PMID 24909177, PMID 25118636

NIH funding

U10CA180886 (20), U10CA098543 (12), P30CA033572 (2), P30CA068485 (2), U01CA097452 (2), U10CA081920 (2), UM1CA228823 (2), 2009 (1), 2023 (1), P01CA034936 (1), P30CA006973 (1), P30CA008748 (1), P30CA015083 (1), P30CA016672 (1), P30CA022453 (1)